Top of the page

Board members of the European Society of Gene and Cell Therapy

The ESGCT Board is composed of researchers and clinicians representing a broad range of European Countries. Board members are elected by nomination and vote at the Annual General Meeting which is usually held during the Annual Congress.

The President and Vice-President of the society are appointed for two years and the other members of the Board are appointed for three years. For full details of governance arrangements please see section 4 of the society constitution. If you would like to express an interest in becoming a Board member please don’t hesitate to contact office@esgct.eu for details of the nomination process.

Member photo Member details
Professor Thierry VandenDriessche, ESGCT President

Professor Thierry VandenDriessche
President

University of Leuven - Faculty of Medicine,
Center for Transgene Technology & Gene Therapy - Flanders Interuniversity Institute for Biotechnology (VIB),
Herestraat 49 B-3000
Leuven
Belgium
Professor Seppo Ylä-Herttuala, ESGCT Vice-President

Professor Seppo Ylä-Herttuala
Vice-President

A.I.Virtanen Institute
University of Kuopio
P.O.Box 1672
70211
Kuopio
Finland
Professor Viggo Van Tendeloo, ESGCT Treasurer

Professor Viggo Van Tendeloo
Treasurer

University of Antwerp
Antwerp University Hospital (UZA)
Wilrijkstraat 10 B-2650
Edegem
Belgium
Professor Len Seymour, General Secretary

Professor Len Seymour
General Secretary

Head of Cancer Research UK Gene Delivery Group,
University of Oxford,
Old Road Campus Research Building,
Headington,
Oxford
OX3 7DQ
Professor Christopher Baum

Professor Christopher Baum

Medizinische Hochschule Hannover
Abt. Experimentelle Haematologie
Carl-Neuberg-Str.1,
OE 6960
D-30625 Hannover
Professor Chiara Bonini

Professor Chiara Bonini

Cancer Immunotherapy and Gene Therapy Program - Experimental Hematology Unit,
Bone Marrow Transplant Unit
Scientific Institute H. S. Raffaele
Via Olgettina 60
20132 Milano
Professor Nathalie Cartier-Lacave

Professor Nathalie Cartier-Lacave

INSERM U745, Faculté de Pharmacie, 2,
avenue de l'Observatoire,
75006 Paris;
France
Professor Klaus Cichutek, Lead contact for scientific committees

Professor Klaus Cichutek
Lead contact for scientific committees

Paul-Ehrlich-Institut
Division of Medical Biotechnology
Paul-Ehrlich-Institut
Paul-Ehrlich-Strasse 51-59
63225 Langen
Germany
Professor Mary Collins

Professor Mary Collins

Windeyer Institute
Immunology and Molecular Pathology
Windeyer Institute
46 Cleveland St
London
Professor Hidde Haisma

Professor Hidde Haisma

Groningen Research Institute for Pharmacy,
Deusinglaan 1,
9713AV Groningen,
The Netherlands
Professor Luigi Naldini

Professor Luigi Naldini

"Università Vita Salute San Raffaele" School of Medicine
San Raffaele Telethon Institute for Gene Therapy
via Olgettina 58,
20132 Milano,
Italia

Submit abstract

Submit abstracts for oral and poster presentation at the Congress
Submit abstract now

Sponsors

ESGCT is very grateful for support from our partners:

Gold sponsors

Link to AFM [opens in a new window]
Link to Genethon [opens in a new window]
Link to Genzyme [opens in a new window]

Platinum sponsors

Link to Clinigene [opens in a new window]
Link to Persist [opens in a new window]
Link to Molmed [opens in a new window]

Silver sponsors

Link to AMT [opens in a new window]
Link to Attack Cancer [opens in a new window]
Link to Cellectis [opens in a new window]
Link to Fresenius BioTech [opens in a new window]
Link to Oxford Biomedica [opens in a new window]
Link to Plasmid Factory [opens in a new window]
Link to Sangamo [opens in a new window]